Your Article Summary
See Latest ArticlesEGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer
Journal of Clinical Oncology, 07/03/08
Kumar B et al. - In a study to prospectively identify markers of response to therapy and outcome in an organ-sparing trial for advanced oropharyngeal cancer, it was shown that low epidermal growth factor receptor (EGFR) and high p16 (or higher human papillomavirus [HPV] titer) expression are markers of good response to organ-sparing therapy and outcome, whereas high EGFR expression, combined low p53/high Bcl-xL expression, female sex, and smoking are associated with a poor outcome
Methods- Pretreatment biopsies were examined for expression of EGFR, p16, Bcl-xL, and p53 as well as for p53 mutation
- These markers were assessed for association with high-risk HPV, response to therapy, and survival
- Pt variables included smoking history, sex, age, primary site, tumor stage, and nodal status
- EGFR expression was inversely associated with response to induction chemotherapy (IC), chemotherapy/radiotherapy (CRT), overall survival (OS), and disease-specific survival (DSS) and was directly associated with current smoking, female sex, and lower HPV titer
- HPV titer was significantly associated with p16 expression; p16 was significantly associated with response to IC, CRT, OS, and DSS
- As combined markers, lower HPV titer and high EGFR expression were associated with worse OS and DSS
- In 36 of 42 biopsies, p53 was wild-type, and only 1 HPV-positive tumor had mutant p53
- Combination of low p53 and high Bcl-xL expression was associated with poor OS and DSS
Related Articles
Understanding the link between HPV and oropharyngeal cancers
JAAPA, 10/20/09
Relevance Score: 69%
Current trends in initial management of oropharyngeal cancer: the declining use of open surgery
European Archives of Oto-Rhino-Laryngology, 10/02/09
Relevance Score: 68%
Oropharyngeal reconstruction using a myomucosal uvular transposition flap following transoral resection of oropharyngeal carcinoma
ENT Journal, 11/20/09
Relevance Score: 66%
Elevated Malondialdehyde Correlates with the Extent of Primary Tumor and Predicts Poor Prognosis of Oropharyngeal Cancer
Anticancer Research, 11/13/09
Relevance Score: 66%
Immunostaining patterns of CD31 and podoplanin in previously untreated advanced oral/oropharyngeal cancer: Prognostic implications
Head & Neck, 11/05/09
Relevance Score: 65%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Expression of p16 in benign and malignant cystic squamous lesions of the neck
Human Pathology, 12/19/09
Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas
Human Pathology, 12/19/09
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
Human Pathology, 12/19/09
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Expression of p16 in benign and malignant cystic squamous lesions of the neck
Human Pathology, 12/19/09
Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas
Human Pathology, 12/19/09
Overexpression of Kif2a promotes the progression and metastasis of squamous cell carcinoma of the oral tongue
Oral Oncology , 12/19/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients
British Journal of Cancer, 12/17/09
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
British Journal of Cancer, 12/17/09
Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis
Annals of Hematology, 12/17/09